← Leaderboards
Yusuf Menda
University Of Iowa
$5,445,305
Attributed
$7,026,752
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,212,686 · 6
By mechanism
R01$5,052,321 · 2
P50$3,907,165 · 3
R21$253,200 · 1
Top collaborators
- M. Sue Sue O'Dorisio5 shared
- James R Howe1 shared
- Dawn E Quelle1 shared
- Michael King Schultz1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- M. Sue Sue O'Dorisio$9,044,145
- James R Howe$4,077,981
- David L Bushnell$1,807,167
- Dawn E Quelle$8,297,216
- Michael Anthony O'Rorke$193,070
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsDiagnosisTumorIncidenceNeuroendocrine TumorsPeptide ReceptorRadiopharmaceuticalsRadionuclide TherapyToxic EffectPre-ClinicalRadiolabeledMalignant NeoplasmsImageInnovationRadiation TherapyEffective TherapyChemotherapyDetectionIsotopesOperative Surgical ProceduresPeptidesAnimalsMouse ModelDesign
Grant awards (22)
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer$2,185,934
P50 · FY2025 · CA
Developmental Research Program$99,299
P50 · FY2025 · CA · contact PI
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors$166,967
R01 · FY2024 · CA · contact PI
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors$503,132
R01 · FY2023 · CA · contact PI
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors$1
R01 · FY2022 · CA · contact PI
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors$606,565
R01 · FY2021 · CA · contact PI
Project 1: Theranostics in Neuroendocrine Tumors$96,189
P50 · FY2021 · CA · contact PI
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors$612,761
R01 · FY2020 · CA · contact PI
Project 1: Theranostics in Neuroendocrine Tumors$58,619
P50 · FY2020 · CA · contact PI
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors$567,395
R01 · FY2019 · CA · contact PI
Project 1: Theranostics in Neuroendocrine Tumors$289,404
P50 · FY2019 · CA · contact PI
Project 1: Theranostics in Neuroendocrine Tumors$302,858
P50 · FY2018 · CA · contact PI
Project 1: Theranostics in Neuroendocrine Tumors$303,328
P50 · FY2017 · CA · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$511,972
R01 · FY2016 · CA
Project 1: Theranostics in Neuroendocrine Tumors$284,340
P50 · FY2016 · CA · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$519,131
R01 · FY2015 · CA
Project 1: Theranostics in Neuroendocrine Tumors$287,194
P50 · FY2015 · CA · contact PI
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$509,922
R01 · FY2014 · CA
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$509,568
R01 · FY2013 · CA
Image-guided Diagnosis and Therapy of Neuroendocrine Tumors$544,907
R01 · FY2012 · CA
Imaging Thymidine Uptake During Treatment for Head and Neck Cancer$111,600
R21 · FY2008 · CA · contact PI
Imaging Thymidine Uptake During Treatment for Head and Neck Cancer$141,600
R21 · FY2007 · CA · contact PI